Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma

Mostrar otras versiones (1)

SIMPLE SUMMARY: Cytokine-induced killer (CIK) cells are a heterogeneous population of polyclonal T effector cells expanded ex vivo. Here, we updated our last review published in 2012 and provided a synopsis of current 15 clinical studies, including 382 patients with renal cell carcinoma (RCC) enroll...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Ellinger, Jörg, Ritter, Manuel, Schmidt-Wolf, Ingo G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564072/
https://www.ncbi.nlm.nih.gov/pubmed/32882824
http://dx.doi.org/10.3390/cancers12092471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564072/
https://www.ncbi.nlm.nih.gov/pubmed/32882824
http://dx.doi.org/10.3390/cancers12092471

Ejemplares similares